Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Non-Clinicians / Medical Office Support Staff / Industry Participants

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend PAINWeekEnd.


Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

DoubleTree by Hilton Sacramento
2001 Point West Way
Sacramento, CA 95815

View hotel website >>

Get Directions using Google Maps


Faculty and courses are subject to change. Please refer to the online agenda below for the most recent course descriptions.

To view the agenda below, click on the + sign next to the day of the conference to expand the conference agenda. Click on the + signs within the agenda to view the course description, UAN number, and AANP pharmacology credits.

*not certified for credit

Saturday, December 7, 2019


    Coffee will be served.

  • Hanging By a Thread: Facial & Orofacial Pain

    Facial pain can be extremely debilitating for the patient and the diagnosis can be extremely difficult for the provider. Facial pain often sends patients to many different subspecialties in search of a cure. This talk will review the diagnosis nd treatment of the most common facial pain conditions including neuropathic pain syndromes, temporal mandibular , and poorly understood disorders such as burning mouth syndrome and persistent idiopathic facial pain.

    • UAN: 0530-0000-19-240-L01-P
    • AANP Rx Hours: 0.10

    Breakfast will be served.

    Sponsored by Legally Mine.


  • Achieving Change from Within: Use of Motivational Interviewing

    Motivational interviewing (MI) is a counseling approach that was initially applied to address drinking behavior. At its core, it helps reduce patients’ ambivalence and move them toward action through use of their own intrinsic motivation. Over the years, MI has been applied broadly across different health domains to help shape outcomes. The approach can be particularly beneficial when working with patients who are perceived to be stuck and not making satisfactory progress in treatment. This presentation will introduce the audience to MI, review the concepts underlying it, and discuss its specific application in pain settings. A video of MI in action will be presented and, as time permits, a live MI demonstration will take place.

    • UAN: 0530-0000-19-239-L01-P
    • AANP Rx Hours: 0.00
  • The Regulatory Agency Will See You Now

    Despite high prevalence and seemingly continuous attention, the clinical challenges associated with assessing, treating, and managing patients with chronic pain continue to persist. Many different forces are at play and responsible for this frequently frustrating situation and, as is often the case, the person with the most at risk is the patient with chronic pain. There is no deficit of opinions for possible solutions to this problem. In fact, the number of potential solutions seems to increase each year, all with the intent of helping pain care be more safe and effective, and most trying to stem the negative consequences of abuse, misuse, and diversion of prescription pain medications. Clinicians have had to juggle these good intentions along with the fear of regulatory scrutiny. This course will present and detail the variety of current regulatory forces that need to be considered in clinical practice; how they can potentially impact clinical decisions regarding chronic pain; and how they can be negotiated. A number of regulatory agencies are now “sitting at the pain management table” for the foreseeable future and it is critical to navigate the waters without sacrificing that most important stakeholder: the patient.

    • UAN: 0530-0000-19-014-L01-P
    • AANP Rx Hours: 0.40



    Lunch will be served.

    Sponsored by AstraZeneca-Daiichi Sankyo, Inc.

  • La Femme Migraneur: The Role of Estrogen in Headaches

    Despite being one of the more frequently noted triggers for migraine, estrogen and its role in the pathology of migraine is still unknown. This talk discusses the current understanding of the role of estrogen in the headache experience. We will start by touching on the clinical experience the field has gathered and then dig into the fledging science on the role of estrogen in the brain, periphery, and blood vessels, and the hypothesis on how these pathways and interactions might trigger the migraine.

    • UAN: 0530-0000-19-241-L01-P
    • AANP Rx Hours: 0.40

  • The Elephant in the Room: Helping Patients to Navigate the "O" Impasse

    A pain psychologist will discuss the role of evidence-based behavioral treatment modalities that are known to result in improvement in physical and emotional functioning, including their use in the context of opioid weaning. The terms dependence, abuse, tolerance, and addiction are often used interchangeably when discussing opioid medication; however, use of the nomenclature in this fashion is erroneous. The differences between these words will be explained and the implications for treatment discussed. Clinical pathways that often lead to medication escalation will be identified. The role of behavioral interventions for pain treatment and the literature supporting their use will be reviewed, including data from an interdisciplinary clinical program which provides patients such education while concurrently reducing opioid medication.

    • UAN: 0530-0000-19-242-L01-P
    • AANP Rx Hours: 0.00
  • The Other Opioid Crisis: Heroin and Fentanyl

    There is a significant amount of media, political, and public attention paid to the opioid crisis/opioid epidemic in the United States today. With the seemingly ever-increasing number of opioid-related overdoses and fatalities, there has been a feverish push by stakeholders to diminish the amount of opioids prescribed in order to help stem these worrisome trends. Unfortunately, there may be a lack of focus regarding the true definition and characterization of the opioid epidemic. There may also be a rush to judgment about the role of appropriately prescribed opioid analgesics in the addiction crisis we face today as well. This presentation will discuss the roles and statistics of both prescription and illicit opioids (namely heroin and fentanyl) in today’s “opioid overdose epidemic” with the intention of clarifying important differences and similarities between these competing epidemics including concerns and clinical considerations specific to each of them. Additionally, this program will examine and identify how these medications and drugs share potentially tragic adverse effect profiles in many cases. However, it is important for clinicians to make sure that appropriate chronic pain patients that may be candidates for opioid analgesic therapy aren’t penalized, and still get the treatment that they deserve.

    • UAN: 0530-0000-19-013-L01-P
    • AANP Rx Hours: 0.00

To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!